Literature DB >> 8593546

Pregnancy-associated osteoporosis.

R Smith1, N A Athanasou, S J Ostlere, S E Vipond.   

Abstract

The clinical features, investigation and outcome in 24 patients with pregnancy-associated osteoporosis, followed for up to 24 years from the first pregnancy are described. Symptoms occurred most often in the first pregnancy (17 patients) at a mean age of 27 years (range 21-36); the most frequent was back pain in late pregnancy or post partum (n = 18); less common was hip (n = 5) or ankle (n = 1) pain. In most, symptoms improved soon after delivery. Four subjects had pre-existing disorders known to reduce bone density (corticosteroid therapy, heparin treatment, mild osteogenesis imperfecta and previous anorexia nervosa). Radiographs showed vertebral collapse or localized osteoporosis of the hip, with MRI evidence of oedema. Forearm bone mineral density (BMD) was sometimes normal, but spinal BMD (measured by DXA) was low. Bone biopsies in eleven patients showed features compatible with osteoblast failure. Except for the patient with mild osteogenesis imperfecta, cultured dermal fibroblasts synthesized and exported normal Type I collagen. In 14 subsequent pregnancies (10 patients) there was no recurrence in ten and mild symptoms in the remainder. Excluding one patient who had repeated osteoporotic fractures and vertebral collapse, the long-term prognosis was good.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593546

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  17 in total

1.  Bisphosphonates in pregnancy and lactation-associated osteoporosis.

Authors:  S M O'Sullivan; A B Grey; R Singh; I R Reid
Journal:  Osteoporos Int       Date:  2006-04-27       Impact factor: 4.507

2.  Sciatica in the female patient: anatomical considerations, aetiology and review of the literature.

Authors:  Abdul-Wahab T Al-Khodairy; Philippe Bovay; Charles Gobelet
Journal:  Eur Spine J       Date:  2006-04-19       Impact factor: 3.134

3.  Effects of pregnancy and lactation on bone mineral density, and their relation to the serum calcium, phosphorus, calcitonin and parathyroid hormone levels in rats.

Authors:  E Gonen; I Sahin; M Ozbek; E Kovalak; S Yologlu; Y Ates
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

Review 4.  Presentation and management of osteoporosis presenting in association with pregnancy or lactation.

Authors:  C S Kovacs; S H Ralston
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

5.  The impact of mammalian reproduction on cancellous bone architecture.

Authors:  S M Shahtaheri; J E Aaron; D R Johnson; S K Paxton
Journal:  J Anat       Date:  1999-04       Impact factor: 2.610

Review 6.  Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature.

Authors:  M Laroche; M Talibart; C Cormier; C Roux; P Guggenbuhl; Y Degboe
Journal:  Osteoporos Int       Date:  2017-09-06       Impact factor: 4.507

7.  Pregnancy-associated osteoporosis: a case-control study.

Authors:  P Hadji; J Boekhoff; M Hahn; L Hellmeyer; O Hars; I Kyvernitakis
Journal:  Osteoporos Int       Date:  2017-01-10       Impact factor: 4.507

8.  Women With Pregnancy and Lactation-Associated Osteoporosis (PLO) Have Low Bone Remodeling Rates at the Tissue Level.

Authors:  Adi Cohen; Mafo Kamanda-Kosseh; David W Dempster; Hua Zhou; Ralph Müller; Elliott Goff; Ivelisse Colon; Mariana Bucovsky; Julie Stubby; Thomas L Nickolas; Emily M Stein; Robert R Recker; Joan M Lappe; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2019-07-26       Impact factor: 6.741

9.  Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy.

Authors:  D Ozdemir; A A Tam; A Dirikoc; R Ersoy; B Cakir
Journal:  Osteoporos Int       Date:  2014-08-20       Impact factor: 4.507

10.  Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating rats.

Authors:  Panan Suntornsaratoon; Kannikar Wongdee; Nateetip Krishnamra; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2009-09-17       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.